During the past decade, Den Urology Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Den Urology Clinic" are "Nocturia" (2 trials), "Bladder Cancer" (1 trials) and "Carcinoma, Transitional Cell" (1 trials). Many other conditions were trialed in "Den Urology Clinic" in a lesser frequency.

Most popular intervention types in "Den Urology Clinic" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "A. Desmopressin 10 microgram" (1 trials), "A: Desmopressin 25 µg" (1 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials) and "B. Desmopressin 50 µg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Den Urology Clinic" are 2 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Den Urology Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Den Urology Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Den Urology Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".